Eficacia del tratamiento y de la profilaxis antifúngica secundaria en la histoplasmosis asociada al sida. Experiencia del Hospital de Infecciosas Francisco J. Muñiz, de la ciudad de Buenos Aires
Ricardo Negroni(Hospital Muñiz), Mário Bianchi(Administración Nacional de Laboratorios e Institutos de Salud), Fernando Messina(Hospital Muñiz), Alicia Arechavala(Hospital Muñiz), Gabriela Santiso(Hospital Muñiz)
Cited by 6
Related Papers
Genomic diversity of the human pathogen Paracoccidioides across the South American continent
|Fungal Genetics and Biology|2020|65
Coronavirus Disease 2019 (COVID-19) in a Patient with Disseminated Histoplasmosis and HIV—A Case Report from Argentina and Literature Review
|Journal of Fungi|2020|56
Lymphocyte Subpopulations and Cytokine Production in Paracoccidioidomycosis Patients
|Microbiology and Immunology|1991|55
High Serum Interleukin-10 and Tumor Necrosis Factor Alpha Levels in Chronic Paracoccidioidomycosis
|Clinical and Diagnostic Laboratory Immunology|2001|36
First case report of tinea corporis caused by Trichophyton indotineae in Latin America
|Medical Mycology Case Reports|2023|36